Knight Therapeutics Inc. (TSE:GUD – Get Free Report) traded down 2% during mid-day trading on Monday . The stock traded as low as C$5.75 and last traded at C$5.77. 38,920 shares traded hands during mid-day trading, a decline of 39% from the average session volume of 63,437 shares. The stock had previously closed at C$5.89.
Knight Therapeutics Trading Down 2.0%
The firm’s 50-day moving average price is C$6.24 and its 200-day moving average price is C$6.03. The company has a quick ratio of 1.79, a current ratio of 3.36 and a debt-to-equity ratio of 7.52. The company has a market cap of C$575.00 million, a P/E ratio of -21.70, a price-to-earnings-growth ratio of -1,013.50 and a beta of 0.05.
Knight Therapeutics Company Profile
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company’s principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets.
Further Reading
- Five stocks we like better than Knight Therapeutics
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- FICO’s Big Dip Could Be the Best Buying Chance of the Year
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- D-Wave: Reevaluating the Short Seller’s Case After the Downgrade
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Datavault: A Speculative AI Play, But Beware of Volatility
Receive News & Ratings for Knight Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Knight Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
